Cubist Pharmaceuticals Inc (NASDAQ:CBST) Investor Alert: Lawsuit Against Takeover Filed

San Diego, CA -- (ReleaseWire) -- 12/22/2014 -- An investor, who currently holds shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), filed a lawsuit in effort to halt the proposed takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.